Search - tctmd.com

Displaying 521 - 540 of 2689

Sort: Relevancy | Date

Presentation THT 2025

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Presenter: Mahir Karakas

February 11, 2025

Presentation THT 2025

Expanding Indications and Options for Ambulatory Hemodynamic Monitoring: Lessons From GUIDE-HF and PROACTIVE-HF

Presenter: Liviu Klein

February 11, 2025

Presentation THT 2025

Catastrophic Migration of an Axillary IABP Salvaged With Endovascular Repair

Presenter: Swagata Patnaik

February 11, 2025

Presentation THT 2025

Harnessing Real World Data to Test Emerging Technologies

Presenter: Robert Yeh

February 11, 2025

Presentation THT 2025

Emerging Questions in the Face of Multiple Effective Therapies

Presenter: Matthew Maurer

February 11, 2025

Presentation THT 2025

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Presenter: Mazen Hanna

February 11, 2025

Presentation THT 2025

How Will We Organize to Manage the Data and Pay for It All?

Presenter: Daniel Bensimhon

February 11, 2025

Presentation THT 2025

Which Heart Failure Patients Need Remote Surveillance, For How Long, and With What Signal?

Presenter: Lynne Stevenson

February 11, 2025

Presentation THT 2025

Time to Escalation: From the Golden Day to the Golden Six Hours

Presenter: Elric Zweck

February 11, 2025

Presentation THT 2025

Are Wearables and Smart Devices a More Scalable Solution

Presenter: Akshay Desai

February 11, 2025

Presentation THT 2025

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Presenter: Shelley Hall

February 11, 2025

Presentation THT 2025

Optimizing Outcomes in Cardiac Arrest and Shock

Presenter: Jacqueline Tamis-Holland

February 11, 2025

Presentation THT 2025

Transcatheter Edge-to-Edge Repair: Buying Time and Function on the Way to Advanced Therapies?

Presenter: Ul Weena

February 11, 2025

Presentation THT 2025

Remote Dielectric Sensing Before and After Discharge in Patients With ADHF

Presenter: Jesús Álvarez-García

February 11, 2025

Presentation THT 2025

Anti-Amyloid Therapy – Will Depleters Change the Game?

Presenter: Scott Solomon

February 11, 2025

Presentation THT 2025

Multiparameter Monitoring via CRM Devices: Ready for Prime Time?

Presenter: John Boehmer

February 11, 2025

Presentation THT 2025

The Catecholaminergic Theory of Takotsubo in Action: A Case of Fulminant Stress Cardiomyopathy Rescued by ECPR in a Young Woman With Pheochromocytoma

Presenter: Alexander Smith

February 11, 2025

Presentation THT 2025

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Presenter: Ahmad Masri

February 11, 2025

Presentation THT 2025

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Presenter: Giada Bianchi

February 11, 2025

Presentation THT 2025

Stabilizers for TTR Amyloidosis: Is One Better Than Another

Presenter: Jan Griffin

February 11, 2025

Advertisement

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Expanding Indications and Options for Ambulatory Hemodynamic Monitoring: Lessons From GUIDE-HF and PROACTIVE-HF

Catastrophic Migration of an Axillary IABP Salvaged With Endovascular Repair

Harnessing Real World Data to Test Emerging Technologies

Emerging Questions in the Face of Multiple Effective Therapies

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

How Will We Organize to Manage the Data and Pay for It All?

Which Heart Failure Patients Need Remote Surveillance, For How Long, and With What Signal?

Time to Escalation: From the Golden Day to the Golden Six Hours

Are Wearables and Smart Devices a More Scalable Solution

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Optimizing Outcomes in Cardiac Arrest and Shock

Transcatheter Edge-to-Edge Repair: Buying Time and Function on the Way to Advanced Therapies?

Remote Dielectric Sensing Before and After Discharge in Patients With ADHF

Anti-Amyloid Therapy – Will Depleters Change the Game?

Multiparameter Monitoring via CRM Devices: Ready for Prime Time?

The Catecholaminergic Theory of Takotsubo in Action: A Case of Fulminant Stress Cardiomyopathy Rescued by ECPR in a Young Woman With Pheochromocytoma

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Stabilizers for TTR Amyloidosis: Is One Better Than Another

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content